학술논문
One percent tenofovir applied topically to humanized BLT Mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the blt model for evaluation of new microbicide candidates
Document Type
Article
Author
Source
In: Journal of Virology . (Journal of Virology, August 2011, 85(15):7582-7593)
Subject
Language
English
ISSN
0022538X
10985514
10985514